Onychomycosis-causing yeasts in four Mexican dermatology centers and their antifungal susceptibility to azolic compounds.;Levaduras causantes de onicomicosis en cuatro centros dermatológicos mexicanos y su sensibilidad antifúngica a compuestos azólicos

Revista Iberoamericana de Micologia

Volumn 28, Issue 1, 2011, Pages 32-35

  Manzano Gayosso, Patricia ^a,b   Méndez Tovar, Luis Javier ^c   Arenas, Roberto ^d   Hernández Hernández, Francisca ^a   Millán Chiu, Blanca ^a   Torres Rodríguez, Josep M ^e   Cortés González, Elda ^a   Fernández, Ramón ^d   López Martínez, Rubén ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b HOSPITAL DE ESPECIALIDADES   (Mexico)

^c HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^d INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^e Hospital General Dario Fernandez Fierro   (Mexico)

Author keywords

Antifungal susceptibility; Candida albicans; Candida parapsilosis; Fluconazole; Itraconazole; Onychomycosis

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA ALBICANS; CANDIDA FAMATA; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; FUNGAL MORPHOLOGY; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; IN VITRO STUDY; MEXICO; NONHUMAN; ONYCHOMYCOSIS; PICHIA GUILLIERMONDII; PROSPECTIVE STUDY;

ADULT; ANTIFUNGAL AGENTS; CANDIDA; CANDIDIASIS, CUTANEOUS; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; HUMANS; ITRACONAZOLE; KETOCONAZOLE; MEXICO; ONYCHOMYCOSIS; PICHIA; PROSPECTIVE STUDIES; RHODOTORULA; SPECIES SPECIFICITY; TRICHOSPORON; YEASTS;

CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA PARAPSILOSIS; DEBARYOMYCES HANSENII; PICHIA GUILLIERMONDII;

EID: 79952312240     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.riam.2010.11.002     Document Type: Article

References (29)

1. Elewski B.E., Charif M.A. Prevalence of onychomycosis in patients attending a dermatology clinic in northeastern Ohio for other condition. Arch Dermatol. 1997, 133:1172-1173.
2. Gupta A.K., Jain H.C., Lynde C.W., Macdonald P., Cooper E.A., Summerbell R.C. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients. J Am Acad Dermatol. 2000, 43(2 Pt 1):244-248.
3. Sarma S., Capoor M.R., Deb M., Ramesh V., Aggarwal P. Epidemiologic and clinicomycologic profile of onychomycosis from north India. Int J Dermatol. 2008, 47:584-587.
4. Souza L.K., Fernandes O.F., Passos X.S., Costa C.R., Lemos J.A., Silva M.R. Epidemiological and mycological data of onychomycosis in Goiania. Brazil. Mycoses. 2010, 53:68-71.
5. El Sayed F., Ammoury A., Haybe R.F., Dhaybi R. Onychomycosis in Lebanon: a mycological survey of 772 patients. Mycoses. 2006, 49:216-219.
6. Svejgaard E.L., Nilsson J. Onychomycosis in Denmark: prevalence of fungal nail infection in general practice. Mycoses. 2004, 47:131-135.
7. Zuluaga de C.A., de Bedout C., Tabares A., Cano L.E., Restrepo A., Arango M., et al. Comportamiento de los agentes etiológicos de la onicomicosis en un laboratorio de micología de referencia (Medellín 1994-2003). Med Cutan Iber Lat Am. 2005, 33:251-256.
8. Manzano-Gayosso P., Hernández-Hernández F., Méndez-Tovar L.J., Palacios-Morales Y., Córdova-Martínez E., Bazán-Mora E., et al. Onychomycosis incidence in type 2 diabetes mellitus patients. Mycopathologia. 2008, 166:41-45.
9. Midgley G., Moore M.K. Onychomycosis. Rev Iberoam Micol. 1998, 15:113-117.
10. Abad-González J., Bonifaz A., Ponce R.M. Onicomicosis por Candida asociada con diabetes mellitus. Dermatología Rev Mex. 2007, 51:135-141.
11. Gupta A.K., Ryder J.E., Baran R., Summerbell R.C. Non-dermatophyte onychomycosis. Dermatol Clin. 2003, 21:257-268.
12. Segal R., Kimchi A., Kritzman A., Inbar R., Segal Z. The frequency of Candida parapsilosis in onychomycosis. An epidemiological survey in Israel. Mycoses. 2000, 43:349-353.
13. Gautret P., Rodier M.H., Kauffmann-Lacroix C., Jacquemin J.L. Case report and review. Onychomycosis due to Candida parapsilosis. Mycoses. 2000, 43:433-435.
14. Manzano-Gayosso P., Méndez-Tovar L.J., Hernández-Hernández F., López-Martínez R. Onicomicosis causada por Candida parapsilosis. Agente ocasional o frecuente. Dermatología Rev Mex. 1997, 41:171-175.
15. Kaur R., Kashyap B., Makkar R. Evaluation of clinicomycological aspects of onychomycosis. Indian J Dermatol. 2008, 53:174-178.
16. Arenas R., Ocejo D. Onicomicosis: frecuencia actual en un departamento de dermatología de la Ciudad de México. Dermatología Rev Mex. 1997, 41:171-175.
17. Gupta A.K., De Doncker P., Haneke E. Itraconazole pulse therapy for the treatment of Candida onychomycosis. J Eur Acad Dermatol Venereol. 2001, 15:112-115.
18. Cornely O.A., Maertens J., Winston D.J., Perfect J., Ullmann A.J., Walsh T.J., et al. Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med. 2007, 356:348-359.
19. Maenza J.R., Merz W.G., Romagnoli M.J., Keruly J.C., Moore R.D., Gallant J.E. Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology. Clin Infect Dis. 1997, 24:28-34.
20. Odds F.C. Resistance of yeasts to azole derivative antifungals. J Antimicrob Chemother. 1993, 31:463-471.
21. Vanden Bossche H., Marichal P., Odds F.C., Le Jeune L., Coene M.C. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob Agents Chemother. 1992, 36:2602-2610.
22. Manzano-Gayosso P., Méndez-Tovar L.J., Hernández-Hernández F., López-Martínez R. La resistencia a los antifúngicos. Un problema emergente en México. Gac Med Mex. 2008, 144:23-26.
23. Daniel C.R., Gupta A.K., Daniel M.P., Sullivan S. Candida Infection of the nail: role of Candida as a primary or secondary pathogen. Int J Dermatol. 1998, 37:904-907.
24. Odds F.C., Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol. 1994, 32:1923-1929.
25. Khan Z.U., Ahmad S., Mokaddas E., Chandy R. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol. 2004, 42:4796-4798.
26. Staib P., Morschhäuser J. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses. 1999, 42:521-524.
27. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved Standard M27-A2. Wayne (PA): National Committee for Clinical Laboratory Standards; 2002.
28. Darko K., Jautova J., Tkáciková L., Wantrubová A. The frequency of Candida species in onychomycosis. Folia Microbiol (Praha). 2002, 47:727-731.
29. Méndez-Tovar L.J., Anides-Fonseca A., Vázquez-Hernández A., Galindo-González M., Díaz-Madrid M., Berdón-Castro A., et al. Micosis observadas en cinco comunidades mexicanas con alto grado de marginación. Gac Méd Méx. 2006, 142:381-386.